Moonpig has overhauled its customer data and marketing systems with Acuity RM to improve targeting precision, operational control and scalable growth...
Aston Martin has agreed a proposed £50m transaction to grant AMR GP perpetual rights to use its name in Formula One operations, pending shareholder approval. FY2025 wholesale volumes declined to 5,448 units, with adjusted EBIT expected slightly below the lower end of analyst forecasts, as the group looks to stronger results in 2026...
NCC Group plc will host a Capital Markets Event for institutional investors and analysts on Friday 13 March 2026, focused on its Cyber business and growth strategy...
For the year ended 31 December 2025, SEGRO achieved record leasing, 6.1% growth in adjusted earnings per share and a 6.0% rise in like-for-like net rental income...
AstraZeneca’s Calquence plus venetoclax has been approved in the US as the first all-oral, 14-month treatment option for adults with CLL and SLL, following Phase III data showing improved progression-free survival versus chemoimmunotherapy...
Oriole Resources has completed a 3,000m maiden diamond drilling programme at the MB01-N target in Cameroon, with remaining assay results due in Q1 2026...
Moonpig has overhauled its customer data and marketing systems with Acuity RM to improve targeting precision, operational control and scalable growth...
Aston Martin has agreed a proposed £50m transaction to grant AMR GP perpetual rights to use its name in Formula One operations, pending shareholder approval. FY2025 wholesale volumes declined to 5,448 units, with adjusted EBIT expected slightly below the lower end of analyst forecasts, as the group looks to stronger results in 2026...
NCC Group plc will host a Capital Markets Event for institutional investors and analysts on Friday 13 March 2026, focused on its Cyber business and growth strategy...
For the year ended 31 December 2025, SEGRO achieved record leasing, 6.1% growth in adjusted earnings per share and a 6.0% rise in like-for-like net rental income...
AstraZeneca’s Calquence plus venetoclax has been approved in the US as the first all-oral, 14-month treatment option for adults with CLL and SLL, following Phase III data showing improved progression-free survival versus chemoimmunotherapy...
Oriole Resources has completed a 3,000m maiden diamond drilling programme at the MB01-N target in Cameroon, with remaining assay results due in Q1 2026...
